Click on the > to read our latest newsletter.
Autumn 2025
Autumn 2024
Autumn 2023
- About AT
About AT
Ataxia Telangiectasia or AT, is a rare and complex genetic disorder. It is often referred to as a ‘multi-system’ disorder because it affects a number of different systems within the body.
- Living with AT
Living with AT
Find out all you need to know about the implications of the Coronavirus for those living with AT.
- How we help
How we help
Our support team, Kay and Anne, are on hand 5 days a week to help and support families living with AT. From the shock of the initial diagnosis through to treatment and the challenges of everyday living, we can provide support, advice and advocacy for people with AT and their family, friends and carers. We also liaise with and offer advice to professionals.
Kay and Anne can be contacted on 01582 760733.
- Support us
Support Us
The AT Society is completely funded by grants and donations, so to keep doing what we do best, we need you to help us. Your support means we can continue to raise awareness. be there with emotional and practical assistance for new families, commission more medical research and provide a vital information resource for everyone involved with AT.
- Shop
Shop
We have a wide range of gifts and fundraising merchandise in our online shop. Every single purchase helps to make a difference to children and their families living with AT.
- Research
Research
Research funded and supported by the AT Society has done a lot to advance our understanding of AT and improve treatments. By bringing top scientists together and exploiting the latest advances in technology we will develop effective ways to treat and ultimately cure AT.
- For Professionals
For Professionals
Ataxia Telangiectasia (AT) is a very rare condition with an estimated 200 cases in the UK. Most professionals will have limited knowledge or be unaware of the condition when a person is referred to them.
- About us
About Us
The AT Society exists to enable people with AT to make the most of the lives they have. We are unique in that we both support people with AT and fund research.
